1. Association Between Hemagglutination Inhibition Antibody Titers and Protection Against Reverse-Transcription Polymerase Chain Reaction–Confirmed Influenza Illness in Children 6–35 Months of Age: Statistical Evaluation of a Correlate of Protection. (25th September 2021) Authors: Danier, Jasur; Callegaro, Andrea; Soni, Jyoti; Carmona, Alfoso; Kosalaraska, Pope; Rivera, Luis; Friel, Damien; Pu, Wenji; Vantomme, Valerie; Dbaibo, Ghassan; Innis, Bruce L; Schuind, Anne; Zaman, Khalequ; Wilson, Jerome Journal: Open forum infectious diseases Issue: Volume 9:Number 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluation of a New Clinical Endpoint for Moderate to Severe Influenza Disease in Children: A Prospective Cohort Study. (14th November 2019) Authors: Rao, Suchitra; Yanni, Emad; Moss, Angela; Lamb, Molly M; Schuind, Anne; Bekkat-Berkani, Rafik; Innis, Bruce L; Cotter, Jillian; Mistry, Rakesh D; Asturias, Edwin J Journal: Journal of the Pediatric Infectious Diseases Society Issue: Volume 9:Number 4(2020) Page Start: 460 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccines. (1st February 2016) Authors: Bekkat-Berkani, Rafik; Ray, Riju; Jain, Varsha K; Chandrasekaran, Vijayalakshmi; Innis, Bruce L Journal: Expert review of vaccines Issue: Volume 15:Number 2(2016) Page Start: 201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial. Issue 6 (June 2021) Authors: Clarke, Ed; Bashorun, Adedapo; Adigweme, Ikechukwu; Badjie Hydara, Mariama; Umesi, Ama; Futa, Ahmed; Ochoge, Magnus; Obayemi, Dolapo; Edem, Bassey; Saidy-Jah, Ebrima; Onwuchekwa, Chukwuemeka; Dhere, Rajeev; Sethna, Vistasp; Kampmann, Beate; Goldblatt, David; Taylor, Douglas; Andi-Lolo, Indah; Hos... Journal: Lancet infectious diseases Issue: Volume 21:Issue 6(2021) Page Start: 834 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial. Issue 1 (January 2020) Authors: Bernstein, David I; Guptill, Jeffrey; Naficy, Abdollah; Nachbagauer, Raffael; Berlanda-Scorza, Francesco; Feser, Jodi; Wilson, Patrick C; Solórzano, Alicia; Van der Wielen, Marie; Walter, Emmanuel B; Albrecht, Randy A; Buschle, Kristen N; Chen, Yao-qing; Claeys, Carine; Dickey, Michelle; Dugan, H... Journal: Lancet infectious diseases Issue: Volume 20:Issue 1(2020) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Prevention of vaccine-matched and mismatched influenza in children aged 6–35 months: a multinational randomised trial across five influenza seasons. (May 2018) Authors: Claeys, Carine; Zaman, Khalequ; Dbaibo, Ghassan; Li, Ping; Izu, Allen; Kosalaraksa, Pope; Rivera, Luis; Acosta, Beatriz; Arroba Basanta, Maria Luisa; Aziz, Asma; Cabanero, Miguel Angel; Chandrashekaran, Vijayalakshmi; Corsaro, Bartholomew; Cousin, Luis; Diaz, Adolfo; Diez-Domingo, Javier; Dinleyi... Journal: Lancet Issue: Volume 2:Number 5(2018) Page Start: 338 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1–2 randomised controlled trial. Issue 7 (July 2022) Authors: Folschweiller, Nicolas; Vanden Abeele, Carline; Chu, Laurence; Van Damme, Pierre; García-Sastre, Adolfo; Krammer, Florian; Nachbagauer, Raffael; Palese, Peter; Solórzano, Alicia; Bi, Dan; David, Marie-Pierre; Friel, Damien; Innis, Bruce L; Koch, Juliane; Mallett, Corey P; Rouxel, Ronan Nicolas; S... Journal: Lancet infectious diseases Issue: Volume 22:Issue 7(2022) Page Start: 1062 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial. (March 2022) Authors: Pitisuttithum, Punnee; Luvira, Viravarn; Lawpoolsri, Saranath; Muangnoicharoen, Sant; Kamolratanakul, Supitcha; Sivakorn, Chaisith; Narakorn, Piengthong; Surichan, Somchaiya; Prangpratanporn, Sumalee; Puksuriwong, Suttida; Lamola, Steven; Mercer, Laina D.; Raghunandan, Rama; Sun, Weina; Liu, Yong... Journal: EClinicalMedicine Issue: Volume 45(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗